Related content

Pediatric Heart Failure Therapy with β-Adrenoceptor Antagonists

By Foerster Susan R.   Canter Charles E.  

Pediatric Drugs, Vol. 10, Iss. 2, 2008-01 ,pp. : 125-134

Adis International

Access to resources Recommend Favorite

Metabolic Effects of β-Adrenoceptor Antagonists with Special Emphasis on Carvedilol

By Kveiborg Britt   Christiansen Buris   Major-Petersen Atheline   Torp-Pedersen Christian  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 4, 2006-01 ,pp. : 209-217

Adis International

Access to resources Recommend Favorite

Optimising the Use of β-Adrenoceptor Antagonists in Coronary Artery Disease

By Ellison Kristin E.  

Drugs, Vol. 65, Iss. 6, 2005-01 ,pp. : 787-797

Adis International

Access to resources Recommend Favorite

Comparison of three radioligands for the labelling of human β-adrenoceptor subtypes

By Niclauß Nadja   Michel-Reher Martina   Alewijnse Astrid   Michel Martin  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 374, Iss. 2, 2006-11 ,pp. : 99-105

Springer Publishing Company

Access to resources Recommend Favorite

Metabolic Profile of Nebivolol, a β-Adrenoceptor Antagonist with Unique Characteristics

By Enrico Agabiti Rosei   Rizzoni Damiano  

Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. : 1097-1107

Adis International

Access to resources Recommend Favorite